Finding a cancer vaccine in Barcelona

by Simon Black · 5 comments

June 24, 2010
Barcelona, Spain

At the spur of the moment, I decided to fly to Barcelona yesterday to attend the ‘Fiesta de San Juan’.  It’s common in many parts of Europe and Latin America to celebrate the official, astrological first day of summer, which also happens to be the longest day (and shortest night) of the year.

In Barcelona, it’s an all night party that includes beach bonfires and a hell of a lot of pyrotechnics.  Thing is, summer solstice was actually on June 21st! The celebration was a couple of days late, just like everything else in Spain I suppose… mañana, mañana.

As is common in my travels, I met a few interesting people during the evening’s festivities. One gentleman was key executive and technical architect at a small biotech firm.

He was attending a conference in Barcelona, and we spoke for over an hour about his company and its major pipeline drug that has recently received FDA approval. Much to my amazement, they’ve managed to synthesize a vaccine that has proven to be incredibly effective in treating certain types of cancer.

In the course of our discussion, he told me about several other companies in the same industry which were deeply undervalued by the market.

“The interesting thing about this industry,” he said, “is that all the science is already public information, published in the medical journals. Our stock prices don’t move, though, for months until the IR department issues a press release. Smart investors have an interim window to scoop up the next breakthrough drug company for pennies.”

He cited a few examples, including one company that had over 9-months between its medical journal publication and press release. The stock barely budged during that time period, but within weeks of the press release it was a 10-bagger.

Not only was I amazed at his company’s biotech breakthroughs, I was even more amazed at the financial implications of his earth-shattering investment revelation.

This is one of the things that I appreciate so much about being an expat and permanent traveler– the exposure to so many compelling opportunities, industry secrets, uncommon wisdom, and interesting people.

These sorts of encounters happen all the time when you step outside out of the daily grind, expose yourself to new surroundings, and maintain an open attitude.

To give you another example, when I was in Brazil last week I met a local businessman who was literally making his living selling shovels to gold miners. His company specializes in importing mining equipment from China and selling it off to Brazilian firms that are mining for gold in the rural provinces.

Based on the volume and type of equipment that the miners are ordering from him, he can tell how close the companies are to striking it rich, or whether they’re just turning big rocks into little rocks. He uses this information, which he kindly shared with me, to reduce his risk in the Brazilian stock market when he speculates on these companies.

His track record is impressive, and his investment gains are far outpacing what he earns from operating the business.  It’s an intriguing model– one that I would not have been exposed to if I had been closed to the opportunity or stuck in a routine.

I’m telling you all of this because I hope to encourage you to shake up your routine a bit in order to increase your exposure to more opportunities, and also cultivate the right mindset for planting multiple flags.

I think travel is a great way to go about doing this… after all, nothing shakes up routine like heading overseas, even if only for a short time.

I’ve been fortunate to meet many subscribers in my travels who are out there doing this– learning, exploring, and benefitting from their unique experiences overseas.  I hope to meet many more in the future as we continue these discussions… perhaps overseas at an upcoming Sovereign Man conference that we plan on organizing.

On that note, I’d like to mention one last thing before I sign off for today; summer solstice was not only a celebration here in Barcelona, but it also coincided with the one year anniversary of launching this letter.

I wanted to take a moment and thank you for your continued subscription. Given all the professional demands I have in my life and the various ventures that I’m involved in, writing this daily letter remains one of my great pleasures simply for the fantastic interaction it affords me with so many interesting people.

Thanks again for being a subscriber, and I look forward to our continued discussions.

Want More Information Like This?
Sign up below for the free newsletter Sovereign Man: Notes From The Field to get more information like the article you just read, plus exclusive information that is not posted publicly.


  • Jai

    Congratulations on your first anniversary of publication. Keep up the great work.

  • SunnyDee123

    Hey Simon (gosh I wish I knew your real name sometimes. How many times have you heard THAT?!) …This note grabbed me fiercely today as cancer has popped into my life a little beyond the comfort level the last few weeks. But I'm not here to harp on that…. in celebration of your one-year and your thanks to “all of us”, I wanted to drop a little note, as simple as it might seem, to you. I honestly don't recall how I stumbled upon you or your site but your Notes From The Field have continued to pull me deeper and deeper into your “world”. In comparison to some of the other comments you get, I feel I might not have much to add, and sometimes even feel a little clueless after reading your topics but it doesn't stop me nonetheless. I don't think I am a simple person yet at times, I might be just that. Regardless, I find myself feeling excited to the point of wanting to research the things I don't understand and wish I had someone to explain them to me face to face….(don't we all)…For now I am content with the exploration of thoughts your notes are creating and so for that, I wanted to thank you – oh mysterious one! Mysterious yet at times I feel like I am reading a note from a friend and wish I could pick up the phone and call and say, “HEY SIMON – I WANT TO COME WITH. HOW CAN WE MAKE IT HAPPEN? …” So anyway, thanks for being a source of eye-opening the last few months. At 41 and single with not many attachments to really speak of, it sure is nice to dream of the possibilities, knowing that I am just the type of person that one day, will make one or two or twenty of them a reality. Life needs a good shake-up these days because my personality no longer fits the career I feel somewhat enslaved to. Plus, I've always believed change is good. Let me know when the next party is and if simple yet open minded people are allowed to come stand in the corner. I will listen intently and smile often :o) Thanks for reading my babble and once again, for giving me something worth reading…it happens from time to time. D

  • PR

    Hi Simon, Would it be possible to provide the name of the 10-bagger stock or the medical journal it was published in (or preferably both) so we can verify this earth-shattering investment revelation? Thanks, PR

  • http://twitter.com/LouAmbrosio Lou Ambrosio

    Could that Cancer Vaccine company be Dendreon? That's the only company I know of that has recently received an FDA approval for prostrate cancer. I'm sure most of your readers are curious

    • Steviewonder

      Hi Lou,

      Yes, it is Dendreon Corporation. Its Provenge vaccine is the first, and so far the only, direct anti-cancer vaccine to receive FDA approval.

      Dendreon has had a rough ride in the markets lately, because of the controversy surrounding medicare funding for the product. At issue is the relatively high cost (around $90k for a course of treatment) for a drug that mostly only saves really old guys who have developed the aggressive form of prostate cancer.

      This is the first really obvious case of the medicare program making value judgements on the relative importance of people's lives when treatments are expensive. For example: using statist logic, it's OK to blow a hundred grand saving the life of a young mother who will probably live a long life and raise her own kids, savin gthe gov't a lot of money, but you're saving a “useless eater” if you spend a hundred grand to save an old guy who might drop dead a year later from a heart attack . . .

      Interestingly, Dendreon's entire production if Provenge is presently spoken for in the private market anyway, which underscores the fact that you have to set yourself up with substantial means for your later years to protect yourself from the bureaucrats who might declare your life not worth saving!

Previous post:

Next post: